{"id":2983,"date":"2018-10-31T09:15:35","date_gmt":"2018-10-31T09:15:35","guid":{"rendered":"https:\/\/lynxee.consulting\/?p=2983\/"},"modified":"2018-11-15T09:55:28","modified_gmt":"2018-11-15T09:55:28","slug":"france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval","status":"publish","type":"post","link":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/","title":{"rendered":"FRANCE &#8211; ANSES: Management of PPPs applications following the renewal of active substances approval"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval. This memo recalls the <\/span><b>regulatory context<\/b><span style=\"font-weight: 400;\"> of the active substances renewal in the framework of Regulation (EC) No. 1107\/2009 and describes the <\/span><b>consequences of the active substances renewal for the applications for PPPs authorisation<\/b><span style=\"font-weight: 400;\"> before and after the active substance renewal, in the case of applications for new PPPs authorisation as well as in the case of PPPs already approved (Article 43).<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Applications related to PPPs for which the authorisation is being renewed under article 43 are classified into <\/span><b>three categories<\/b><span style=\"font-weight: 400;\"> described in the memo: applications essentially administrative that may be processed during the process of authorisation renewal, applications that cannot be processed by ANSES during the period of evaluation of the authorisation renewal (frozen period) and applications that may be processed in parallel with the renewal authorisation, for which the evaluation cannot be finalised before \u00a0the renewal evaluation is complete.<\/span><span style=\"font-weight: 400;\"><br \/>\n<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Finally, the <\/span><b>theoretical timelines for the renewal of PPP authorisations<\/b><span style=\"font-weight: 400;\"> pursuant to Article 43 of Regulation (EC) No.1107\/2009 and to the <\/span><a href=\"https:\/\/ec.europa.eu\/food\/sites\/food\/files\/plant\/docs\/pesticides_aas_guidance_renewal_1107-2009.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Guidance document on the Renewal of Authorisations<\/span><\/a><span style=\"font-weight: 400;\"> is set out in appendix and details on the definition of the frozen period are given.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><b>To download: <\/b><\/p>\n<p><a href=\"https:\/\/www.anses.fr\/fr\/system\/files\/Note_info_gestion_AMM_renouvellement_substancesactives.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Gestion des demandes relatives \u00e0 la mise sur le march\u00e9 de produits phytopharmaceutiques suite au renouvellement de l\u2019approbation de substances actives<\/span><\/a> <span style=\"font-weight: 400;\">(in French)<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><b>Lynxee consulting<\/b><span style=\"font-weight: 400;\">\u2019s team is at your disposal to answer your questions.<\/span><\/p>\n<p><b>Contact us!<\/b> <a href=\"https:\/\/lynxee.consulting\/en\/contact\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">https:\/\/lynxee.consulting\/en\/contact\/<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval. This memo recalls the regulatory<span class=\"excerpt-hellip\"> [\u2026]<\/span><\/p>\n","protected":false},"author":6,"featured_media":2981,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36],"tags":[64,97,98],"class_list":["post-2983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-regulation","tag-anses-en","tag-article-43-en","tag-renewal"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.1.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting<\/title>\n<meta name=\"description\" content=\"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting\" \/>\n<meta property=\"og:description\" content=\"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"Lynxee consulting\" \/>\n<meta property=\"article:published_time\" content=\"2018-10-31T09:15:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-11-15T09:55:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"603\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Florence Dupeuble\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Florence Dupeuble\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/\",\"url\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/\",\"name\":\"FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting\",\"isPartOf\":{\"@id\":\"https:\/\/lynxee.consulting\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg\",\"datePublished\":\"2018-10-31T09:15:35+00:00\",\"dateModified\":\"2018-11-15T09:55:28+00:00\",\"author\":{\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/c158e1e5ec125a45877f1172fde8a2a5\"},\"description\":\"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.\",\"breadcrumb\":{\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage\",\"url\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg\",\"contentUrl\":\"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg\",\"width\":1920,\"height\":603},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/lynxee.consulting\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FRANCE &#8211; ANSES: Management of PPPs applications following the renewal of active substances approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lynxee.consulting\/#website\",\"url\":\"https:\/\/lynxee.consulting\/\",\"name\":\"Lynxee consulting\",\"description\":\"Innovative support for regulatory issues\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lynxee.consulting\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/c158e1e5ec125a45877f1172fde8a2a5\",\"name\":\"Florence Dupeuble\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7282b6b2cb13e8a8dce05b02d54b5191fc5c3736e7920212ea5eea79d548ba15?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7282b6b2cb13e8a8dce05b02d54b5191fc5c3736e7920212ea5eea79d548ba15?s=96&d=mm&r=g\",\"caption\":\"Florence Dupeuble\"},\"url\":\"https:\/\/lynxee.consulting\/en\/author\/florence\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting","description":"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/","og_locale":"en_US","og_type":"article","og_title":"FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting","og_description":"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.","og_url":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/","og_site_name":"Lynxee consulting","article_published_time":"2018-10-31T09:15:35+00:00","article_modified_time":"2018-11-15T09:55:28+00:00","og_image":[{"width":1920,"height":603,"url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg","type":"image\/jpeg"}],"author":"Florence Dupeuble","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Florence Dupeuble","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/","url":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/","name":"FRANCE - ANSES: Management of PPPs applications following the renewal of active substances approval - Lynxee consulting","isPartOf":{"@id":"https:\/\/lynxee.consulting\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage"},"image":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg","datePublished":"2018-10-31T09:15:35+00:00","dateModified":"2018-11-15T09:55:28+00:00","author":{"@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/c158e1e5ec125a45877f1172fde8a2a5"},"description":"ANSES published on 18.10.2018 a memo describing the management of applications for PPPs authorisation following the renewal of active substances approval.","breadcrumb":{"@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#primaryimage","url":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg","contentUrl":"https:\/\/lynxee.consulting\/wp-content\/uploads\/2018\/10\/maple-1079235_1920.jpg","width":1920,"height":603},{"@type":"BreadcrumbList","@id":"https:\/\/lynxee.consulting\/en\/france-anses-management-of-ppps-applications-following-the-renewal-of-active-substances-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/lynxee.consulting\/en\/"},{"@type":"ListItem","position":2,"name":"FRANCE &#8211; ANSES: Management of PPPs applications following the renewal of active substances approval"}]},{"@type":"WebSite","@id":"https:\/\/lynxee.consulting\/#website","url":"https:\/\/lynxee.consulting\/","name":"Lynxee consulting","description":"Innovative support for regulatory issues","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lynxee.consulting\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/c158e1e5ec125a45877f1172fde8a2a5","name":"Florence Dupeuble","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/lynxee.consulting\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7282b6b2cb13e8a8dce05b02d54b5191fc5c3736e7920212ea5eea79d548ba15?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7282b6b2cb13e8a8dce05b02d54b5191fc5c3736e7920212ea5eea79d548ba15?s=96&d=mm&r=g","caption":"Florence Dupeuble"},"url":"https:\/\/lynxee.consulting\/en\/author\/florence\/"}]}},"_links":{"self":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/comments?post=2983"}],"version-history":[{"count":3,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2983\/revisions"}],"predecessor-version":[{"id":2989,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/posts\/2983\/revisions\/2989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media\/2981"}],"wp:attachment":[{"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/media?parent=2983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/categories?post=2983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lynxee.consulting\/en\/wp-json\/wp\/v2\/tags?post=2983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}